Found 52 matching trials
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma
EARLY_PHASE1This is an Open-label, Single Arm study to observe the safety and tolerabil...
Location
Shanghai Tenth People's Hospital
A Study of GPC3 Redirected Autologous T Cells for Advanced HCC
PHASE1Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
PHASE1Patients may be considered if the cancer has come back, has not gone away a...
Location
Texas Children's Hospital
Clinical Study of Intratumoral Injection of CAR-T Cells in the Treatment of Advanced Liver Tumors
EARLY_PHASE1Objective to study the safety and preliminary efficacy of intratumoral inje...
Location
The Fifth Medical Center of Chinese PLA General Hospital
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
PHASE1The purpose of this study is to collect the date on the safety and potentia...
Location
Shanghai Tumor Hospital
CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma
PHASE1In this single-center, single-arm, prospective, open-label Phase 1/2 study,...
Location
Biotherapeutic Department of Chinese PLA General Hospital
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
PHASE1This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Location
Peking University Shenzhen Hospital
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
PHASE1This Phase 1, open-label, non-randomized study will enroll pediatric and yo...
Location
Seattle Children's Hospital
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
PHASE1A study that aimed to assess the safety and anti-tumor activity of CCAR031 ...
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
EARLY_PHASE1This is a single-arm, open-label, dose-escalation clinical trial designed t...
Location
Beijing Gobroad Hospital